Introduction of algorithms used to forecast future hypoglycemia based on CGM trends and insulin-on-board led to predictive low glucose suspend (PLGS), including the MiniMed 640G (Medtronic, Northridge, California) and the Basal-IQ system (Tandem Inc., San Diego, California) [100,101]. The gene discussed is INS; the disease is Hypoglycemia.